In contrast, a GPC3-specific MRI probe comprising the currently used Gd contrast agent may be more readily integrated into clinical workflows and may even be used in combination with functional MRI techniques to provide a comprehensive assessment of tumor biology [42,43]. Here, GPC3 is linked to neoplasm.